Home/Filings/4/0001127602-25-001837
4//SEC Filing

Francois Cedric 4

Accession 0001127602-25-001837

CIK 0001492422other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 3:28 PM ET

Size

9.1 KB

Accession

0001127602-25-001837

Insider Transaction Report

Form 4
Period: 2025-01-22
Francois Cedric
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2025-01-22$30.43/sh13,551$412,296418,519 total
Holdings
  • Common Stock

    (indirect: By Trust)
    472,065
  • Common Stock

    (indirect: By Trust)
    234,411
  • Common Stock

    (indirect: By Trust)
    532,946
  • Common Stock

    (indirect: By Trust)
    300,000
Footnotes (5)
  • [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 21, 2025.
  • [F2]The securities are held by The Cedric Francois Irrevocable Trust of 2023 - 2. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023 - 2. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 - 2 except to the extent of his pecuniary interest therein.
  • [F3]The securities are held by The Cedric Francois Irrevocable Trust of 2023. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
  • [F4]The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.
  • [F5]The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1
  • filerCIK 0001658080

Filing Metadata

Form type
4
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 3:28 PM ET
Size
9.1 KB